Together, these data establish PPARγ expression as a context‐dependent regulator of breast cancer outcome, linking adipose metabolism, tumor hormonal expression, and tumor behavior—supporting its potential as a biomarker and therapeutic target in metabolically vulnerable subgroups, paving the way for more personalized medicine. This evidence concerns the gene PPARG and breast cancer.